Global Inclusion & Diversity Report - Bristol Myers Squibb

GLOBAL INCLUSION & DIVERSITY REPORT

Leading with our
Value of Inclusion

 

Driving equitable advancement and outcomes for all

Mother and daughter together on a back porch


"Something new and refreshing is taking shape"
 
 
 
English 繁體中文 (Chinese – Traditional) 简体中文  (Chinese – Simplified) Français  (French)
日 本語 (Japanese) 한 국어(Korean) Español  (Spanish) Рycckий (Russian)
Português do Brasil (Brazilian Portuguese) Nederlands  (Dutch) Deutsch (German) Italiano  (Italian)
 
Inclusion & Diversity strengthen the I.D. and foundation of Bristol Myers Squibb
 
 

We are guided by a single vision —
 
Transforming Patients' Lives Through Science

 

To fully realize this vision, we have relied on the strength of our rich history and long-standing commitment to inclusion and diversity to ensure that we can drive meaningful impact and outcomes for our patients and communities, our colleagues, and our business and industry.

Our evolved Global Inclusion & Diversity strategy and priorities are the first steps on that path forward.

 
 
 

Bristol Myers Squibb and the Bristol Myers Squibb Foundation: Inclusion & Diversity impact by the numbers

 
 
 

Global executive gender parity


45.5%
of global executives were women in 2021 vs. 42.6% in 2020




Diversity in clinical trials: Bringing clinical trials to diverse communities


54%
of U.S. clinical trial sites were located in highly diverse communities in 2021

Addressing health disparities in the U.S.


$27.9M
across 107 grants was awarded to support the health disparity efforts of non-profit organizations and external partners in 2021

Black/African American U.S. executive*

 

4.5%
of U.S. executives were Black/African American in 2021 vs. 2.4% in 2020


Latino/Hispanic U.S. executive*

 

7.2%
of U.S. executives were Latino/Hispanic in 2021 vs. 4.2% in 2020

Asian American U.S. executive*

 

17.7%
of U.S. executives were Asian American in 2021 vs. 16.7% in 2020


*Vice President or higher

Supplier diversity spending

 

$899M
in spending with diverse businesses in 2021 vs. $695M in 2020

Supplier diversity spending

 

45%
growth in supplier diversity spending between 2019 and 2021

Bristol Myers Squibb Foundation Diversity in Clinical Trials Award Program

 

52
scholars selected through the Bristol Myers Squibb Foundation's Robert A. Winn Diversity in Clinical Trials Award Program

Bristol Myers Squibb Foundation Diversity in Clinical Trials Award Program

 

73%
of Robert A. Winn Diversity in Clinical Trial scholars come from groups underrepresented in medicine


Bristol Myers Squibb Foundation Employee Giving Program


$802K
awarded to social justice organizations (September 2020 – December 2021)

 

*Bristol Myers Squibb donates to the Bristol Myers Squibb Foundation, an independent charitable organization.

Our Value of Inclusion circles the globe

 

We are guided by a single vision — transforming patients’ lives through science. To fully realize this vision, we have relied on the strength of our rich history and long-standing commitment to inclusion and diversity to ensure that we can drive meaningful impact and outcomes for our patients and communities, our colleagues, and our business and industry. Our evolved Global Inclusion & Diversity strategy and priorities are the first steps on that path forward.

Leading with our Value of Inclusion: Global Inclusion & Diversity refreshed strategy

 

Our Global Inclusion & Diversity strategy has three pillars focused on critically important stakeholders. 

Patients and Communities

Drive innovation & growth to address the unmet needs of our increasingly diverse patients and communities around the world.

Colleagues

Lead with our Value of Inclusion to advance a workplace where our colleagues feel they belong, and their unique perspectives are valued and rewarded, while building a global workforce that reflects the diverse cultures, backgrounds and experiences of our patients and communities globally. 

Business & Industry

Reimagine and transform business and industry practices, processes and policies to achieve equitable advancement and outcomes for all.

 

The journey continues — Inclusion leading the way

 

We are proud of our company’s commitment to Inclusion & Diversity and the meaningful steps we are taking to drive equitable advancement and outcomes for all. Our collaborative efforts to foster inclusion require transparency across our organization. We want our workforce, partners and patients to be aware of our culture of inclusion and the commitment we have for continued growth in service to our patients around the world.


NEXT SECTION